Cairo – Mubasher: Minapharm Pharmaceuticals registered consolidated net profits of EGP 209.65 million during the first nine months of 2020, up by 183.6% year-on-year (YoY) from EGP 73.91 million, including minority shareholders’ rights.
The company’s revenues increased to EGP 1.65 billion in the January-September period from EGP 1.5 billion in the corresponding period a year earlier, according to a bourse disclosure on Sunday.
During the first half (H1) of 2020, the pharmaceuticals company achieved net profits of EGP 130.11 million, compared to EGP 50.8 million in H1-19.
